These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 16278037)

  • 1. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
    Arya SC; Agarwal N
    Vaccine; 2008 Jan; 26(3):291. PubMed ID: 18082292
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
    Hatunceva NV; Mironova MV; Ryapolova RG
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
    [No Abstract]   [Full Text] [Related]  

  • 8. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)].
    Meshalova AN; Kurlova VI; Yanisker GY; Lavrovskaya VM; Blant ME; Negina YP
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):167-71. PubMed ID: 4216250
    [No Abstract]   [Full Text] [Related]  

  • 9. Status of paratyphoid fever vaccine research and development.
    Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
    Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
    Pakkanen SH; Kantele JM; Kantele A
    Scand J Immunol; 2014 Mar; 79(3):222-9. PubMed ID: 24383914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Schwartz E
    N Engl J Med; 2009 Nov; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccines for typhoid fever and other salmonelloses.
    Martin LB
    Curr Opin Infect Dis; 2012 Oct; 25(5):489-99. PubMed ID: 22825288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization against typhoid: a short review.
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 1994 May; 42(5):424. PubMed ID: 7829448
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against typhoid fever: present status.
    Ivanoff B; Levine MM; Lambert PH
    Bull World Health Organ; 1994; 72(6):957-71. PubMed ID: 7867143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.
    Wahid R; Fresnay S; Levine MM; Sztein MB
    Mucosal Immunol; 2015 Nov; 8(6):1349-59. PubMed ID: 25872480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.
    Levine MM; Ferreccio C; Black RE; Lagos R; San Martin O; Blackwelder WC
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S24-8. PubMed ID: 17582564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.